Original paper
LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Abstract
Inhaled bronchodilators (alone or in combination) are the cornerstone of treatment for symptomatic patients with COPD, either as initial/first-line treatment or for second-line/treatment escalation in patients who experience persistent symptoms or exacerbations on monotherapy. The Global Initiative for Chronic Obstructive Lung Disease 2022 report recommends initial pharmacological treatment with a long-acting muscarinic antagonist (LAMA) or a...
Paper Details
Title
LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Published Date
Nov 8, 2022
Journal
Volume
11
Issue
22
Pages
6623 - 6623